These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 28224237

  • 1. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M, Sadeghizadeh M, Javan M.
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [Abstract] [Full Text] [Related]

  • 2. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K, Brück W, Kuhlmann T.
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [Abstract] [Full Text] [Related]

  • 3. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA, Akirav EM.
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [Abstract] [Full Text] [Related]

  • 4. Overcoming remyelination failure in multiple sclerosis and other myelin disorders.
    Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ.
    Exp Neurol; 2010 Sep; 225(1):18-23. PubMed ID: 20044992
    [Abstract] [Full Text] [Related]

  • 5. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
    Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, Ffrench-Constant C, Franklin RJ, Hoekstra D, Zhao C, Baron W.
    Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
    [Abstract] [Full Text] [Related]

  • 6. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK.
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [Abstract] [Full Text] [Related]

  • 7. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
    Kremer D, Küry P, Dutta R.
    Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
    [Abstract] [Full Text] [Related]

  • 8. Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism.
    Jia Y, Zhang D, Li H, Luo S, Xiao Y, Han L, Zhou F, Wang C, Feng L, Wang G, Wu P, Xiao C, Yu H, Du J, Bao H.
    Biochem Pharmacol; 2021 Mar; 185():114422. PubMed ID: 33482151
    [Abstract] [Full Text] [Related]

  • 9. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
    Marro BS, Skinner DD, Cheng Y, Grist JJ, Dickey LL, Eckman E, Stone C, Liu L, Ransohoff RM, Lane TE.
    J Virol; 2019 Sep 15; 93(18):. PubMed ID: 31243125
    [Abstract] [Full Text] [Related]

  • 10. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS, Blakemore WF.
    Adv Exp Med Biol; 1999 Sep 15; 468():183-97. PubMed ID: 10635029
    [Abstract] [Full Text] [Related]

  • 11. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE, Kuhlmann T, Antel JP.
    Biochim Biophys Acta; 2011 Feb 15; 1812(2):184-93. PubMed ID: 20887785
    [Abstract] [Full Text] [Related]

  • 12. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE, Bourne JN, Evangelou AV, Khandker L, Macklin WB, Wood TL.
    J Neurosci; 2017 Aug 02; 37(31):7534-7546. PubMed ID: 28694334
    [Abstract] [Full Text] [Related]

  • 13. Remyelinating strategies in multiple sclerosis.
    Luessi F, Kuhlmann T, Zipp F.
    Expert Rev Neurother; 2014 Nov 02; 14(11):1315-34. PubMed ID: 25331418
    [Abstract] [Full Text] [Related]

  • 14. Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.
    Huang JK, Fancy SP, Zhao C, Rowitch DH, Ffrench-Constant C, Franklin RJ.
    Neurotherapeutics; 2011 Oct 02; 8(4):650-8. PubMed ID: 21904791
    [Abstract] [Full Text] [Related]

  • 15. Endogeneous remyelination: findings in human studies.
    Kipp M, Victor M, Martino G, Franklin RJ.
    CNS Neurol Disord Drug Targets; 2012 Aug 02; 11(5):598-609. PubMed ID: 22583436
    [Abstract] [Full Text] [Related]

  • 16. p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
    Marziali LN, Hwang Y, Palmisano M, Cuenda A, Sim FJ, Gonzalez A, Volsko C, Dutta R, Trapp BD, Wrabetz L, Feltri ML.
    Brain; 2024 May 03; 147(5):1871-1886. PubMed ID: 38128553
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination.
    Galloway DA, Gowing E, Setayeshgar S, Kothary R.
    Glia; 2020 May 03; 68(5):859-877. PubMed ID: 31441132
    [Abstract] [Full Text] [Related]

  • 18. Signals to promote myelin formation and repair.
    Taveggia C, Feltri ML, Wrabetz L.
    Nat Rev Neurol; 2010 May 03; 6(5):276-87. PubMed ID: 20404842
    [Abstract] [Full Text] [Related]

  • 19. Why does remyelination fail in multiple sclerosis?
    Franklin RJ.
    Nat Rev Neurosci; 2002 Sep 03; 3(9):705-14. PubMed ID: 12209119
    [Abstract] [Full Text] [Related]

  • 20. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J.
    J Neurocytol; 2002 Sep 03; 31(6-7):523-36. PubMed ID: 14501221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.